Publications by authors named "Gregory A Vidal"

Claim this Profile
Q
Qualitative Interviews on the Experience of Orally vs. Intramuscularly Administered Endocrine Therapy for Advanced Breast Cancer: Patient and Healthcare Provider Perspectives.
Rebecca M Speck, Gale Harding, Aarti R Chawla, Christine R Agius, Shakeela W Bahadur, Gregory A Vidal

Oncol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden.
Xin Hu, Clara Cai, Sara Arshad, Janeane N Anderson, Mylin A Torres, Gregory A Vidal

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing health literacy gaps in adjuvant endocrine therapy adherence: Post hoc insights from a randomized remote monitoring trial.
Ilana Graetz, Samuel Hernandez, Xin Hu, Rebecca A Krukowski, Janeane N Anderson, Gregory A Vidal

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial.
Xin Hu, Rebecca A Krukowski, Edward Stepanski, Janeane N Anderson, Gregory A Vidal

J Natl Compr Canc Netw· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived discrimination, patient-provider communication, and quality of life among breast cancer survivors: a mediation analysis.
Freddie Yang, Xin Hu, Janeane N Anderson, Gregory A Vidal, Edward Stepanski

J Cancer Surviv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer.
Janeane N Anderson, Andrew J Paladino, Ryan Blue, Derek T Dangerfield, Susan Eggly, Gregory A Vidal

J Cancer Surviv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19-Related Financial Hardship and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage Breast Cancer.
Sara Arshad, Xin Hu, Rebecca A Krukowski, Teresa M Waters, Gregory A Vidal

Health Serv Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy.
Rebecca A Krukowski, Xin Hu, Sara Arshad, Janeane N Anderson, Edward Stepanski, Gregory A Vidal

JCO Clin Cancer Inform· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro, Joanne Xiu, Kelsey Poorman, Gregory A Vidal

Cancer Res Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.
Anthony D Elias, Alyse W Staley, Monica Fornier, Gregory A Vidal, Vida Alami

NPJ Breast Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.
Nadine Tung, Charité Ricker, Hans Messersmith, Judith Balmaña, Susan Domchek, Gregory A Vidal

J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial.
Ilana Graetz, Xin Hu, Mehmet Kocak, Rebecca A Krukowski, Janeane N Anderson, Gregory A Vidal

JAMA Netw Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
Gregory A Vidal, Neha Jain, Aaron Fisher, Daniel Sheinson, Katherine T Lofgren

JCO Oncol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Peter Schmid, Nicholas C Turner, Carlos H Barrios, Steven J Isakoff, Sung-Bae Kim, Gregory A Vidal

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
Gregory A Vidal, Patricia Chalela, Andrea N Curry, Bassel El-Rayes, Balazs Halmos

Contemp Clin Trials· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, Sharon Sams, Lyndsey S Crump, Gregory A Vidal

NPJ Breast Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial.
Ilana Graetz, Xin Hu, Andrea N Curry, Andrew Robles, Gregory A Vidal

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.
David L Saltman, Matthew G Varga, Tyler J Nielsen, Nicole S Croteau, Heather M Lockyer, Gregory A Vidal

Clin Lung Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer.
Xin Hu, Cameron M Kaplan, Michelle Y Martin, Mark S Walker, Edward Stepanski, Gregory A Vidal

Cancer Epidemiol Biomarkers Prev· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events.
Mengni Guo, Ari M VanderWalde, Xinhua Yu, Gregory A Vidal, G Gary Tian

Clin Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer.
Xin Hu, Mark S Walker, Edward Stepanski, Cameron M Kaplan, Michelle Y Martin, Gregory A Vidal

JAMA Netw Open· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
Nadia Harbeck, Harold J Burstein, Sara A Hurvitz, Stephen Johnston, Gregory A Vidal

Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Harsha Ranganath, Amit L Jain, Justin R Smith, Julie Ryder, Amina Chaudry, Gregory A Vidal

BMC Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices.
Gregory A Vidal, Santosh Gautam, Anna Vlahiotis, Maxine D Fisher, Sonia Pulgar

Future Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care.
Janeane N Anderson, Rebecca A Krukowski, Andrew J Paladino, J Carolyn Graff, Lee Schwartzberg, Gregory A Vidal

J Hosp Manag Health Policy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis